BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27885263)

  • 1. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.
    Ge Z; Gu Y; Han Q; Zhao G; Li M; Li J; Chen B; Sun T; Dovat S; Gale RP; Song C
    Sci Rep; 2016 Nov; 6():38004. PubMed ID: 27885263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
    Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
    Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
    Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
    Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
    J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.
    Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S
    Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
    Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C
    Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
    Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
    J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
    Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
    Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
    Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
    Medeiros BC
    N Engl J Med; 2009 Apr; 360(17):1787; author reply 1787-8. PubMed ID: 19387020
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
    Churchman ML; Qian M; Te Kronnie G; Zhang R; Yang W; Zhang H; Lana T; Tedrick P; Baskin R; Verbist K; Peters JL; Devidas M; Larsen E; Moore IM; Gu Z; Qu C; Yoshihara H; Porter SN; Pruett-Miller SM; Wu G; Raetz E; Martin PL; Bowman WP; Winick N; Mardis E; Fulton R; Stanulla M; Evans WE; Relling MV; Pui CH; Hunger SP; Loh ML; Handgretinger R; Nichols KE; Yang JJ; Mullighan CG
    Cancer Cell; 2018 May; 33(5):937-948.e8. PubMed ID: 29681510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
    Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
    Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.